• Home
  • Expertise
  • Work
  • About
  • News
  • Contact
  • Home
  • Expertise
  • Work
  • About
  • News
  • Contact
Facebook-f X-twitter Linkedin-in Instagram

News

 
  • Client News
  • Commentary
  • eNewsletter
  • OWC News
  • Client News

CURE Pharmaceutical featured on Strategic Investor Radio

Listen to Rob Davidson, CEO of CURE Pharmaceutical and corporate board member for several companies in the industry, discuss this…
Read Full Story
  • Client News

CURE Pharmaceutical and United Smart Cities launch healthcare initiative

CURE Pharmaceutical, an innovative drug delivery and development company, today announced a global healthcare awareness initiative with United Smart Cities…
Read Full Story
  • Client News

CURE Pharmaceutical to acquire privately-held Chemistry Holdings Inc., expanding its technology platform in oral drug delivery

Oxnard-based CURE Pharmaceutical announced plans to acquire formulation technology company Chemistry Holdings Inc. in an all-stock transaction. The deal will allow…
Read Full Story
  • Client News

CURE Pharmaceutical joins forces with Canopy Growth in exclusive partnership

CURE Pharmaceutical has signed a deal with Canopy Growth Corp (TSX:WEED, NYSE:CGC), where Canopy will have an exclusive license to…
Read Full Story

Contact Us

SEE HOW WE CAN ACCELERATE YOUR BUSINESS TODAY!

10940 Wilshire Blvd., Suite 1210
Los Angeles, CA 90024

T: 310.824.9000
F: 310.824.9007
info@olmsteadwilliams.com

Facebook-f X-twitter Linkedin-in Instagram